The longtime entrepreneur describes the realities of founding a cultivated meat company, and offers insights for other founders and CEOs in the space.
The San Francisco startup says it has found a way to bring down the cost of cultivated meat manufacturing with biotechnology and machine learning.
Alt meat, seafood, dairy, and egg companies can use the reporting frameworks to standardize their ESG impact for investors and consumers.
Both plant-based and cultivated meats are marked as areas for R&D in China’s Five-Year Plan that sets economic goals for the country.
Eat Just secured world-first regulatory approval in Singapore for its GOOD Meat cultivated chicken back in December 2020.
Evolved Meats’ co-founders share how their startup makes whole-cut cultivated meat without scaffolding or binders.
Insect protein and bio-textiles increasing in importance as alternative proteins become a bigger priority for climate-forward investors.
Alternative protein and eGrocery grabbed the bulk of the top 15 deals in 2021, but midway through 2022, the future for one of them is far less certain.
Andreessen Horowitz led the Series A round, which will enable SCiFi to continue R&D on its blend of plant-based and cultivated beef burgers.
Innovative Food was 2021’s most active agrifoodtech investment category, driven by mega-deals for the likes of Impossible Foods and Perfect Day.
Pending regulatory approval, the US-based company hopes to bring its cultivated chicken to commercial markets later this year.
SuperMeat’s co-founder and head of communications talks regulatory approvals, transparency with consumers, and the long-term promise of cultivated meat.
Food and ag offer significant emissions reduction opportunities; but only if changes are made to farming, eating, and everything in between, the report states.
The Japanese startup is one of several companies that have discovered methods for removing animal serum from the cell culture process.
Lowercarbon Capital led the round.
Xi said that China “should shift our focus from farmland only” and use biotechnology to “obtain calories and protein from plants, animals, and microorganisms.”
Latin America and the Middle East also saw their respective shares of global alt-protein funding increase year-on-year.
The firm has made the first close of its $15 million maiden fund, which it claims is the first to exclusively back Asia Pacific alt-protein startups.
But the startup needs to get regulatory approval before it can sell its cell-cultured salmon to US consumers.
Cultivated meat and other “future foods” startups raised a total of $127 million in China during 2020.
Sponsored
Sponsored post: The innovator’s dilemma: why agbioscience innovation must focus on the farmer first